ARC Pharmaceuticals granted brand-new U.

Currently marketed items for preventing surgical adhesions, such as films, gels and sprays, are both difficult to use and only effective marginally. ARC’s groundbreaking technology combines simplicity, reduced surgery effectiveness and time.. ARC Pharmaceuticals granted brand-new U.S. Patent ARC Pharmaceuticals Inc. announced today that The University of British Columbia has been granted a new US patent entitled ‘Pharmaceutical Compositions and Methods Associated with Fucans, No. 6,812,220. The patent protects key intellectual property specifically licensed to ARC that may be used in the development of ARC’s lead product candidates for the treatment of surgical adhesions.Coding, reimbursement, and quality reporting under ICD-10 all depend on the precision of doctor documentation. Hospitals should begin physician education now to build competency well in advance of ICD-10 implementation.’ Related StoriesInnovation in anaesthesia: an interview with Matti Lehtonen, GE HealthcareRE.WORK showcases potential technology and innovations in deep learning softwareUsing integrated molecular pathology to control incidental pancreatic cysts: an interview with Dr Ananya Das The 3M ICD-10 Education Program leverages nearly 30 years of 3M coding experience and knowledge gained from a lot more than 1,500 3M clinical documentation improvement consulting engagements.